Panbela Therapeutics, Inc.

PBLA · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$7-$7-$7-$6
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$4$7-$2$3
Other Non-Cash$10-$1$0$0
Operating Cash Flow-$2-$1-$9-$3
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0-$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$8
Investing Cash Flow$0$0$0-$8
Financing Activities
Debt Repay.$2$0-$1$0
Stock Issued$0$0$8$5
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$5
Financing Cash Flow$2$0$7$5
Forex Effect$0$0-$0$0
Net Chg. in Cash$0-$0-$2$2
Supplemental Information
Beg. Cash$0$0$3$1
End Cash$0$0$0$3
Free Cash Flow-$2-$1-$9-$3
Panbela Therapeutics, Inc. (PBLA) Financial Statements & Key Stats | AlphaPilot